• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Copley Scientific introduces new products for nasal spray testing

Copley Scientific, which recently made multiple updates to its range of OINDP testing equipment, has announced the launch of a new range of accessories for testing nasal sprays, including metered dose and dry powder nasal products. The new Copley products include accessories for delivered dose uniformity (DDU) testing of nasal products as well as for improved in vitro-in vivo correlations in aerodynamic particle size distribution (APSD) testing of nasal products.

According to the company, the new Nasal Spray Dose Collector (NSDC) and Nasal Spray Waste Collector (NSWC) can be used for manual test methods or in conjunction with the company’s Vertus II/Plus automated shake and fire system to improve reproducibility of DDU testing.

The new Alberta Idealised Nasal Inlet (AINI), like the Alberta Idealised Throat and Child Alberta Idealised Throat, was developed by University of Alberta professor Warren Finlay. According to Copley, the aluminum inlet “is made up of four individual regions – the vestibule, turbinate, olfactory and nasopharynx – and mimics deposition behavior in each while simultaneously generating a sample that accurately reflects the respirable dose.”

The company adds that accessories also allow the Vertus II/Plus to interface with widely-used types of cascade impactors for APSD testing to evaluate nasal versus lung deposition, saying that “use of the Vertus II/Plus with cascade impactors such as the Next Generation Impactor and Andersen Cascade Impactor for this application, reduces measurement variability, boosts productivity, and alleviates health and safety concerns.”

Read the Copley Scientific press release.

Share

published on March 11, 2021

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Aptar Pharma banner
    © 2025 OINDPnews